Illumina (ILMN) Financials

The financial statement of Illumina Inc (ILMN) provides a comprehensive overview of the company's financial performance. The income statement shows the revenue and expenses incurred during a specific period. It includes metrics such as gross profit, EBIT (earnings before interest and taxes), EBITDA (earnings before interest, taxes, depreciation, and amortization), and net income from stockholders. The total revenue reflects the company's overall sales and is a key indicator of its financial health. Illumina Inc's balance sheet reveals the company's assets, liabilities, and stockholders' equity. It includes figures such as cash equivalents, net debt, total assets, total debt, and total liabilities. Cash flow statements provide insights into how the company generates and uses cash. It consists of operating cash flow, investing cash flow, and financing cash flow. Lastly, free cash flow is an important metric that measures the company's cash generation after accounting for capital expenditures.

Illumina Inc (ILMN) has displayed strong financial performance in recent years. The company's income statement shows consistently increasing revenue, driven by strong demand for its genomic sequencing instruments and consumables. Gross profit has also experienced significant growth, reflecting the company's ability to effectively manage costs. EBIT and EBITDA have shown consistent positive trends, indicating strong profitability. Net income from stockholders has followed a similar positive trajectory. The company's balance sheet reveals a healthy financial position, with ample cash equivalents and positive stockholders' equity. Total assets have steadily increased, highlighting the company's investments in research and development and growth initiatives. Total debt has been minimal, resulting in low total liabilities. Illumina Inc has consistently generated positive cash flow from its operations, allowing it to fund its growth strategies. The company has efficiently managed its cash flow, resulting in positive free cash flow. Overall, Illumina Inc's financials exhibit a strong and stable financial foundation.